Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2095532Generated: October 31, 2026

3-{4-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-7-oxo-[1,4]diazepan-1-yl}-propionic acid → 1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-4-[3-((3RS,4SR)-3,4-dihydroxy-piperidin-1-yl)-3-oxo-propyl]-[1,4]diazepan-5-one

https://huagongshe.com/reaction/2095532

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-{4-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-7-oxo-[1,4]diazepan-1-yl}-propionic acidHCID 67074538—
Reactant(cis)-(Rac)-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-piperidineHCID 131727826—
Product1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-4-[3-((3RS,4SR)-3,4-dihydroxy-piperidin-1-yl)-3-oxo-propyl]-[1,4]diazepan-5-oneHCID 8956814895%

Reaction Steps

In analogy to the procedure described in Example 1,3-{4-[(E)-3-(3,4-dichloro-phenyl)-acryloyl]-7-oxo-[1,4]diazepan-1-yl}-propionic acid (intermediate 5) and (cis)-(rac)-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-piperidine (intermediate 9) gave the titled compound in 95% yield as a white solid. MS: 712.5 (MH+, 2Cl).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08445674B2
Source datasetuspto-grants-2013_05
ORD IDord-d806f45733a64896a09020ae61455881
Source noteuspto-grants-2013_05